Orlando, FL -- (SBWIRE) -- 09/18/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages. To Join Our Text Message Alerts Service Just Text The Word Stocks To 555888 From Your Cell Phone. Our Focus Today Is On Kythera Biopharmaceuticals Inc(NASDAQ:KYTH), Repros Therapeutics Inc(NASDAQ:RPRX), Perion Network Ltd(NASDAQ:PERI).
Stocks of Repros Therapeutics Inc(NASDAQ:RPRX) and biotechs Kythera Biopharmaceuticals Inc(NASDAQ:KYTH) surged post reports of good clinical-trials on their drug candidates.
Kythera jumped by 25% as it confirmed that the two late-stage trials of ATX-101, injection for reduce double chins, successfully achieved primary and secondary endpoints. Analyst Seamus Fernandez of Leerink raised the price target on the firm as he felt that the low-single-digit dropout rate is manageable.
On the other hand, Goldman Sachs rated the stock as neutral. The company shares have surged by over 40% since mid-August before the recent announcement.
Cowen's Ken Cacciatore opined that the value may be higher if it becomes a target for buyout. He added that the lack of viable aesthetic products may make it a wealth-creating decision for acquisition of the asset. Repros also came out with positive results on two studies involving effectiveness as well as safety of testosterone-replacement drug Androxal.
The firms said over 75% of subjects with hypogonadism have been successful in controlling testosterone levels.
Analyst Jonathan Aschoff of Brean Capital raised the price target from 32 to 41 for the firm citing possibility of buyout with even management expressing interest for selling it. Its stock was up by 30% above the previous day’s price.
Are investors worried about the recent updates with RPRX? Find out with a free trend analysis HERE
A recent report by Benchmark Company analyst Daniel L. Kurnos has suggested a Buy rating on Perion Network Ltd(NASDAQ:PERI) raising price target from $16 to $19.
Benchmark opined that Perion entered into a reverse merger with portion of privately-held search giant Conduit in all-stock transaction.
The shareholders of Conduit shareholders would get 81% stake in Perion in return for Conduit's Client Connect business that had revenues of about $280 million in revenue as well as $89 million in EBITDA.
As a result, Perion would be third largest affiliate search provider as well as the fourth largest US search provider having a domestic market share of 2%.
Is PERI going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
Join Our Mobile SMS Alerts By Texting Stocks To 555888
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)